Discover the transforming power of Nu-Derm with this trial-size kit. The Nu-Derm system offers a complete prescription-strength regimen that helps to diminish the appearance of age spots, dark spots, freckles, hyperpigmentation, and discoloration.
The Obagi Nu-Derm System Trial Kit comes in a six-week supply and is TSA-friendly.
INGREDIENTS: Hydroquinone 4%
Strong inhibitor of melanin production that has long been established as the most effective ingredient for reducing and potentially eliminating melasma
See individual products for the full ingredients list:
Obagi Nu-Derm Gentle Cleanser (2 oz)
Obagi Nu-Derm Toner (2 oz)
Obagi Nu-Derm Clear (2 oz)
Obagi Nu-Derm Exfoderm (1 oz)
Obagi Nu-Derm Blender (1 oz)
Sun Shield™ Matte Broad Spectrum SPF 50 (1 oz)
With a 30-year legacy of science and innovation, Obagi has led transformative research that has met the needs of every skin tone and type. We believe skin care is more than “correcting” or even “preventing,” it’s about unleashing your skin’s full potential. That’s why at Obagi we create inclusive products that support the diversity we all bring to the table. It’s about developing scientifically backed, clinical-quality formulations to promote healthy, future-facing skin.
IMPORTANT SAFETY INFORMATION
Obagi Nu-Derm Clear, Blender and Sunfader (contains 4% hydroquinone)
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS:
- Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
- Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
- Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
| Skin Type |
Normal To Dry, Normal To Oily |
|---|